Actinic Keratosis Treatment Market Size, Share, Growth Potential, Opportunities & Trends 2022-2027 | 3M Company, Almirall SA

 Breaking News
  • No posts were found

Actinic Keratosis Treatment Market Size, Share, Growth Potential, Opportunities & Trends 2022-2027 | 3M Company, Almirall SA

October 19
16:42 2022
Actinic Keratosis Treatment Market Size, Share, Growth Potential, Opportunities & Trends 2022-2027 | 3M Company, Almirall SA
Actinic Keratosis Treatment Market Report 2022-2027
The global market is majorly driven by the rising prevalence of actinic keratosis and the growing need for preventive strategies for cancer.

According to the latest report by IMARC Group, titled “Actinic Keratosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global actinic keratosis treatment market size reached US$ 5.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2027, exhibiting a growth rate (CAGR) of 5.27% during 2022-2027. Actinic keratosis is a skin disorder that causes rough and scaly patches on the face, lips, ears, neck, forearms, and scalp due to prolonged exposure to the sun. Other factors, such as old age, severe baldness, skin wrinkles, and the high tendency to sunburn, also make a person more predisposed to develop the disease. Topical medications, photodynamic therapy, combination therapy, and surgical procedures, such as chemical peel, cryosurgery, curettage, and laser surgery, are some common treatment methods. These procedures promote the growth of healthy skin cells and ease symptoms, such as itching, pain, or tenderness.

Request to Get the Sample Report:

The rising prevalence of actinic keratosis due to ozone layer depletion and chronic sun damage to the skin is one of the key factors driving the market growth. Furthermore, the rising demand for minimally invasive (MI) therapies and the increasing awareness of the disease are acting as other growth-inducing factors. Additionally, the introduction of artificial intelligence (AI) and deep learning-based image classification methods to support clinicians and enhance their efficiency in identifying and diagnosing actinic keratosis is providing an impetus to market growth. Besides this, increasing drug approvals and extensive research and development (R&D) activities to formulate novel therapies with improved efficacy are anticipated to drive the market growth.

Actinic Keratosis Treatment Market 2022-2027 Competitive Analysis and Segmentation:


The competitive landscape of the global actinic keratosis treatment market has been studied in the report with the detailed profiles of the key players operating in the market.


Competitive Landscape with Key Players:

  • 3M Company (NYSE: MMM)
  • Almirall SA (BME: ALM)
  • Bausch Health Companies Inc. (NYSE: BHC)
  • Biofrontera Inc. (NASDAQ: BFRI)
  • BioLineRx Ltd. (NASDAQ: BLRX)
  • Cipher Pharmaceuticals Inc (OTCMKTS: CPHRF)
  • Galderma SA
  • Hill Dermaceuticals Inc.
  • LEO Pharma A/S
  • Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA)


Key Highlights of the Market Segmentation:

The global actinic keratosis treatment market report has categorized the market based on type, drug type, distribution channel and region.


Breakup by Type:

  • Prescription
  • OTC


Breakup by Drug Type:

  • Fluorouracil
  • Imiquimod
  • Diclofenac
  • Others


Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Stores


Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa


Explore Report Description with TOC & List of Figure:


Key Highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape


If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.


Browse More Trending Reports:

Neurological Biomarkers Market

Antifungal Drugs Market

About Us: 

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States

Related Articles